Early Rectal Cancer
Early rectal cancer refers to cancer that starts in the rectum and is diagnosed at an early stage, often before it has spread significantly. Symptoms may include changes in bowel habits, rectal bleeding, and abdominal discomfort.
Rectal Polyps: SGM-101 Fluorescent Tracer Study
We are investigating a new imaging technique using SGM-101 to help identify cancerous and non-cancerous tissues in patients with rectal polyps. This study aims to improve how doctors detect early-stage rectal cancer.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Are you pregnant or breastfeeding?
- Have you ever had an anaphylactic shock (a severe allergic reaction)?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Sgm-101
Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Leids Universitair Medisch Centrum (LUMC)
Surgery
Leiden, Netherlands
Sponsor: Academisch Ziekenhuis Leiden
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.